Psychedelic Drug Stocks Plummet On FDA Advisers’ Doubts About Ecstasy Candidate

view original post

Stocks for companies developing psychedelic treatments fell Wednesday after advisers to the Food and Drug Administration voted against a mental-health therapy using the drug MDMA, sometimes known as Ecstasy.